Cigna Group announced Monday it is not pursuing a merger with Humana. The announcement squashes speculation fueled by Donald ...

"The Cigna Group remains committed to its established M&A criteria and would only consider acquisitions that are ...

Analyst Steve Baxter of Wells Fargo maintained a Hold rating on Cigna (CI – Research Report), retaining the price target of $355.00.

Additionally, in light of recent and persistent speculation, The Cigna Group expects to communicate that the company is not ...

The cryptocurrency market saw huge moves over the weekend following the Fed's decision last week to cut interest rates by ...

Last December, the two companies failed to agree on a price as Cigna pursued the purchase of the Louisville-based company.

The potential merger of Cigna and Humana could have a better chance of success than under the Democrats, though we still see increasing claims concentration in the PBM industry as a concern. Also, the ...

Company officials said Monday they are not pursuing a merger with rival Humana, causing Cigna's stock to rise in the markets.

Shares of Cigna Group (NYSE: CI), the healthcare company, were rising today after the company announced in a press release ...

Cigna stock now sports a 13.6% year-to-date lead. The shares are on track for their best single-session gain of the year, and ...

The flat-out denial comes after Cigna CEO David Cordani tried to discourage persistent speculation of a Humana merger earlier ...

Despite reports that merger talks were back on, Cigna officially squashed rumors that it was looking to acquire Humana in a ...